Sepracor's (R,R)-formoterol demonstrates fast-onset, long-lasting effects on FEV1 in phase IIa study April 28, 1999
University of Michigan team establishes role of IL-17 in pathogenesis of acute lung injury April 23, 1999
Preparation, activity, compositions and use of CCR3 receptor antagonists described by Roche April 20, 1999